Search results for “Auxilium”

Times Square Tower

document TEXT-001-HOUSE_OVERSIGHT_024003.txt House Oversight Committee — Epstein Estate Records (Nov 2025)

… Pharmaceuticals, Principia BioPharma and VaxInnate. He was previously on the boards of NxStage Medical (NASDAQ: NXTM), Auxilium (NASDAQ: AUXL), ePocrates (NASDAQ: EPOC, acquired by athenahealth), Nuvelo (NASDAQ: NUVO), Sapient Health Network (acquired by WebMD), Spotfire (acquir...

Leadership: NLV_ are leaders in biopharmaceutical investing across all stages and transaction

document IMAGES-007-HOUSE_OVERSIGHT_024045.txt House Oversight Committee — Epstein Estate Records (Nov 2025)

…exited in sale to Biogen Idec, 1.8x multiple plus milestones), Chimerix (NLV-IL, IPO - April, 2013, NASDAQ: CMRxX), and Auxilium (Sprout IX, NASDAQ: AUXL, exited at 4.6x). e Restructuring Private Companies: The Fund Managers have led financings that have restructured private com...

NLV-III will be managed by the New Leaf team, which currently manages NLV-I, NLV-IL, and

document IMAGES-007-HOUSE_OVERSIGHT_024022.txt House Oversight Committee — Epstein Estate Records (Nov 2025)

… Pharmaceuticals, Principia BioPharma and VaxInnate. He was previously on the boards of NxStage Medical (NASDAQ: NXTM), Auxilium (NASDAQ: AUXL), ePocrates (NASDAQ: EPOC, acquired by athenahealth), Nuvelo (NASDAQ: NUVO), Sapient Health Network (acquired by WebMD), Spotfire (acquir...

Sprout Capital IX, L.P. (Healthcare Technology Portfolio)

document IMAGES-007-HOUSE_OVERSIGHT_024102.txt Mar 31, 2014 House Oversight Committee — Epstein Estate Records (Nov 2025)

…herapeutics 2004 23.2 151.7 - 151.7 6.54 Aureon Biosciences, Inc. Diagnostics & Infrastructure 2001 34.1 0.8 - 0.8 0.02 Auxilium Pharmaceuticals, Inc. Therapeutics 2003 23.1 106.3 - 106.3 4.60 Corixa Corporation. Therapeutics 2003 42.7 31.1 - 31.1 0.73 eHealth, Inc. Convergence 2...

Results for “Auxilium”

Names that match “Auxilium”